Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Shoulder Innovations, Inc.NYSE: SI
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities rises 44.9% from a year ago
Other current liabilities stood at $6.37M at the end of Q1 FY2026, up 44.9% from a year earlier and up 181.3% from the prior quarter.
Context
- Other current liabilities amounted to 4.0% of total assets at the end of Q1 FY2026, down 3.7 pp from a year earlier.
- Other current liabilities increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +44.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- (7.83M) USD
- Year-over-year change
- -1514.1%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (7.83M) | -1514.1% |
| FY2024 | 2024-12-31 | 554K | +143.0% |
| FY2023 | 2023-12-31 | 228K | — |
Other Current Liabilities vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 other current liabilities of $6.37M is the 5th highest of the 11 companies compared; the peer median is $5.73M.
- Its year-over-year change of +44.9% is the 3rd highest of 10, against a peer median of +18.0%.
- Other current liabilities amounts to 4.0% of total assets for SI, versus a peer median of 3.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $25.03M | -24.1% | +152.2% | 18.9% | |
| Mar 2026 | $12.95M | +18.0% | -35.0% | 5.2% | |
| Mar 2026 | $11.38M | -31.9% | +9.1% | 4.0% | |
| Mar 2026 | $9.1M | -35.3% | -47.4% | 24.5% | |
| Mar 2026 | $6.37M | +44.9% | — | 4.0% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $6.3M | +199.7% | — | 4.3% |
| Dec 2025 | $5.16M | +34.0% | -14.6% | 3.2% | |
| Mar 2026 | $3.92M | — | — | 1.2% | |
| Mar 2026 | $2.64M | +5.9% | +83.3% | 1.5% | |
| Mar 2026 | $2.37M | +29.6% | +132.4% | 1.0% | |
| Mar 2026 | $1.52M | +204.8% | +280.2% | 1.5% | |
| Peer median (excluding SI) | $5.73M | +18.0% | +46.2% | 3.6% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.